Redeye makes upward estimate revisions on the back of I-Tech’s solid Q1 figures. Delivering organic growth of 34% in the quarter confirms that Q4’23-figures was only a bump in the road. We argue that
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/
© Modular Finance, source